Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 19.3415.6115.8318.4817.89

What is the latest Core EBITDA Margin ratio of BLISS GVS PHARMA ?

The latest Core EBITDA Margin ratio of BLISS GVS PHARMA is 19.34 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202419.34
Mar202315.61
Mar202215.83
Mar202118.48
Mar202017.89

How is Core EBITDA Margin of BLISS GVS PHARMA Trending?

Years Core EBITDA Margin % Change
Mar2024 19.34
23.89
Mar2023 15.61
-1.39
Mar2022 15.83
-14.34
Mar2021 18.48
3.30
Mar2020 17.89 -

Other Financial Ratios of BLISS GVS PHARMA


Compare Core EBITDA Margin ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,266.4 Cr 0.1% -5.1% -0.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,188.0 Cr -1.5% 4.6% 3% Stock Analytics
DIVIS LABORATORIES ₹143,074.0 Cr -4.8% -3.2% 40.7% Stock Analytics
CIPLA ₹115,768.0 Cr -1.3% -1.9% -5.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,809.0 Cr 1.1% 6.1% 27.1% Stock Analytics
DR REDDYS LABORATORIES ₹92,503.5 Cr -3.6% -2.7% -11.4% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

0.1%

-5.1%

-0.9%

SENSEX

-2.4%

0.7%

0.5%


You may also like the below Video Courses